A Phase 3, Randomized, Double Blind, Comparative Study of Micafungin Versus Placebo as Preemptive Antifungal Therapy in Patients in the Intensive Care Unit at High Risk for Developing Fungal Infection
Robert G Sawyer
Department of Surgery
Project Sponsored By: Fujisawa Healthcare, Inc.
Start Date: 9/1/2002
- End Date: 6/30/2005
|